GORMAN KEVIN CHARLES (Chief Executive Officer) received a stock award from NEUROCRINE BIOSCIENCES INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/15/2026ACC: 0001201096-26-000018
DirectorOfficer· Chief Executive Officer
Since Feb 2019
+6.50K
Net shares
Net buyer
$1.22M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
14.34K acquired · 7.84K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.34K
Price / share
—
Trade value
—
% of position
2.8%
9/11/2026
511.29K→525.64K
Common Stock
Direct
Shares
−7.84K
Price / share
$156.22
Trade value
$1.22M
% of position
1.5%
9/11/2026
525.64K→517.80K
Total
Net shares
+6.50K
Net value
-$1.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2026 | A · Award | +14.34K | — | — | 2.8% | 511.29K | 525.64K |
| Common Stock Direct | 9/11/2026 | F · Tax Withholding | −7.84K | $156.22 | $1.22M | 1.5% | 525.64K | 517.80K |
| Total | +6.50K | -$1.22M | ||||||
Derivative Transactions0
No derivative transactions reported